Oncology

Latest News

Slideshow: Pharmacists’ Ability to Improve Patient Care in Cancer Medication Management Services
Slideshow: Pharmacists’ Ability to Improve Patient Care in Cancer Medication Management Services

April 5th 2024

In 4 posters presented at the Hematology/Oncology Pharmacy Association Annual Conference 2024, researchers addressed pharmacists’ role in managing patients’ anticancer medications.

New OTC Colon Cancer Test Makes Screening More Accessible, Affordable
New OTC Colon Cancer Test Makes Screening More Accessible, Affordable

March 25th 2024

Mirvetuximab Soravtansine for FRα+ Platinum-Resistant Ovarian Cancer Gets Full FDA Approval
Mirvetuximab Soravtansine for FRα+ Platinum-Resistant Ovarian Cancer Gets Full FDA Approval

March 22nd 2024

Blood-Based Test Demonstrates High Sensitivity for Colorectal Cancer
Blood-Based Test Demonstrates High Sensitivity for Colorectal Cancer

March 15th 2024

FDA Approves Lisocabtagene Maraleucel For Treatment of Relapsed or Refractory CLL, SLL
FDA Approves Lisocabtagene Maraleucel For Treatment of Relapsed or Refractory CLL, SLL

March 15th 2024

Latest CME Events & Activities

Translating Progress in BCMA-Directed Therapy for Multiple Myeloma into Advances in Patient Care

1.0 Credit / Hematology, Oncology

View More

Enhancing the Safety of Outpatient CAR T-Cell Administration in Relapsed/Refractory Lymphomas Through Pharmacist-Directed Initiatives

1.0 Credit / Hematology, Oncology

View More

Optimizing Safe Use of Antibody-Drug Conjugates in Solid Tumors Through Pharmacist Interventions

1.0 Credit / Oncology

View More

Ushering in a New Era of Targeted Therapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Focus on New and Emerging Antibody-Based Regimens

1.0 Credit / Hematology, Oncology

View More

Optimizing Outcomes for Older Patients With Acute Myeloid Leukemia: A Focus on Alternative Induction Regimens and Maintenance Therapy

1.0 Credit / Hematology, Oncology

View More

Continuing the Conversation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Addressing Operational Challenges and Integrating New and Emerging Antibody-Based Regimens

1.0 Credit / Hematology, Oncology

View More

Treatment Strategies for Chronic Myeloid Leukemia and the Pharmacist’s Impactful Role

1.0 Credit / Hematology, Oncology

View More

Navigating Current and Emerging Treatment Options for Myelofibrosis After Frontline Failure

1.0 Credit / Oncology

View More

Optimizing Treatment of Early-Stage Breast Cancer and the Pharmacist’s Role in Managing Targeted Therapies

1.5 Credits / Oncology

View More

Enhancing Care for Patients With Endometrial Cancer Through Pharmacist Interventions

1.0 Credit / Oncology, Women’s Health

View More

Targeted Therapies for Non-Small Cell Lung Cancer With ROS1 or KRAS Mutations and the Impact of Pharmacists’ Care

1.0 Credit / Oncology, Pulmonology/Respiratory

View More

Investigating Novel Strategies for the Treatment of Metastatic Small Cell Lung Cancer After Frontline Treatment Failure

1.0 Credit / Oncology

View More

Perspectives on Emerging Data for the Use of Immunotherapy in the Treatment of Early-Stage Non-Small Cell Lung Cancer

1.5 Credits / Oncology, Pulmonology/Respiratory

View More

Managed Care Considerations on the Evolving Role of Bispecific Antibodies in Hematologic Malignancies

1.5 Credits / Hematology, Oncology

View More

Clinical Updates and Strategies for Optimizing Use of Bispecific Antibodies in Hematologic Malignancies

1.0 Credit / Oncology

View More

Promoting Adherence in Early-Stage HR+/HER2- Breast Cancer: The Value of Oncology Pharmacists in Preventing Premature Treatment Discontinuation

1.25 Credit(s) / Oncology; Women’s Health

View More

Continuing the Conversation in Myelofibrosis: The Role of Managed Care in Supporting Treatment Goals Through Appropriate Use of Emerging Therapies

1.0 Credits / Hematology, Oncology

View More

Caring for Patients With Chronic Graft-versus-Host Disease: The Important Role of Pharmacists on the Cancer Care Team

1.5 Credits / Hematology, Oncology

View More

New Frontiers in the Treatment of Lower-Risk Myelodysplastic Syndromes and the Role of Oncology Pharmacists

1.5 Credit / Hematology, Oncology

View More

Advances in EGFR Exon 20 Insertion-Positive Non–Small Cell Lung Cancer: A Focus on Specialty Pharmacy Interventions

1.5 Credits / Oncology, Pulmonology/Respiratory

View More

Improving Pharmacists' Knowledge of Endometrial Cancer and Solutions for Equity and Medication Access

1.5 Credits / Endocrinology, Diabetes & Metabolism, Oncology

View More

Clinical Updates in AML Induction and Maintenance Regimens and the Role of the Specialty Pharmacist

1.5 Credit(s) / Hematology, Oncology

View More

Managed Care Approaches to Improve Outcomes in Frontline Therapy for Advanced Renal Cell Carcinoma

1.0 Credit / Oncology

View More

Demystifying the Details of T-Cell Engaging Bispecific Antibodies: Establishing a Foundation for Oncology Pharmacists

2.0 Credits / Oncology

View More

Continuing the Conversation: A Review of Targeted Therapies for Early-Stage Breast Cancer

0.5 Credit / Oncology, Women’s Health

View More

The Impact of Antibody-Drug Conjugates in Bladder Cancer and Gynecologic Malignancies

1.0 Credit / Oncology

View More

Opportunities to Optimize Treatment of Non-Small Cell Lung Cancer and Gastric Cancers With Antibody-Drug Conjugates

1.0 Credit / Oncology

View More

Assessing the Role of Antibody-Drug Conjugates in Breast Cancer Treatment Pathways

1.0 Credit / Oncology

View More

Exploring the Value of Pharmacist-Led Toxicity Management for New and Emerging Antibody-Drug Conjugates Across Solid Tumors

1.25 Credits / Oncology

View More

Improving Patient Outcomes in TNBC: Immunotherapy, PARP, TROP2, Oh My!

2.0 Credits / Oncology

View More

More News

© 2024 MJH Life Sciences

All rights reserved.